A randomized first-in-human phase I trial of differentially adjuvanted Pfs48/45 malaria vaccines in Burkinabé adults.
Saved in:
| Title: | A randomized first-in-human phase I trial of differentially adjuvanted Pfs48/45 malaria vaccines in Burkinabé adults. |
|---|---|
| Authors: | Tiono AB; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso., Plieskatt JL; Department for Congenital Disorders, Statens Serum Institut (SSI), Copenhagen, Denmark., Ouedraogo A; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso., Soulama BI; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso., Miura K; Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, USA., Bougouma EC; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso., Naghizadeh M; Department for Congenital Disorders, Statens Serum Institut (SSI), Copenhagen, Denmark.; Centre for Medical Parasitology at Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark., Barry A; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso., Yaro JBB; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso., Ezinmegnon S; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso., Henry N; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso., Ofori EA; Department for Congenital Disorders, Statens Serum Institut (SSI), Copenhagen, Denmark.; Centre for Medical Parasitology at Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark., Adu B; Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana, Legon, Accra, Ghana., Singh SK; Department for Congenital Disorders, Statens Serum Institut (SSI), Copenhagen, Denmark.; Centre for Medical Parasitology at Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark., Konkobo A; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso., Lövgren Bengtsson K; Novavax AB, Uppsala, Sweden., Diarra A; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso., Carnrot C; Novavax AB, Uppsala, Sweden., Reimer JM; Novavax AB, Uppsala, Sweden., Ouedraogo A; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso., Tienta M; Malaria Research and Training Center, Mali-National Institute of Allergy and Infectious Diseases International Center for Excellence in Research, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali., Long CA; Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, USA., Ouedraogo IN; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso., Sagara I; Malaria Research and Training Center, Mali-National Institute of Allergy and Infectious Diseases International Center for Excellence in Research, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali., Sirima SB; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso., Theisen M; Department for Congenital Disorders, Statens Serum Institut (SSI), Copenhagen, Denmark.; Centre for Medical Parasitology at Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark. |
| Source: | The Journal of clinical investigation [J Clin Invest] 2024 Apr 01; Vol. 134 (7). Date of Electronic Publication: 2024 Apr 01. |
| Publication Type: | Clinical Trial, Phase I; Randomized Controlled Trial; Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model: Electronic Cited Medium: Internet ISSN: 1558-8238 (Electronic) Linking ISSN: 00219738 NLM ISO Abbreviation: J Clin Invest Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38290009 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: A randomized first-in-human phase I trial of differentially adjuvanted Pfs48/45 malaria vaccines in Burkinabé adults. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Tiono+AB%22">Tiono AB</searchLink>; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso.<br /><searchLink fieldCode="AU" term="%22Plieskatt+JL%22">Plieskatt JL</searchLink>; Department for Congenital Disorders, Statens Serum Institut (SSI), Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Ouedraogo+A%22">Ouedraogo A</searchLink>; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso.<br /><searchLink fieldCode="AU" term="%22Soulama+BI%22">Soulama BI</searchLink>; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso.<br /><searchLink fieldCode="AU" term="%22Miura+K%22">Miura K</searchLink>; Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Bougouma+EC%22">Bougouma EC</searchLink>; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso.<br /><searchLink fieldCode="AU" term="%22Naghizadeh+M%22">Naghizadeh M</searchLink>; Department for Congenital Disorders, Statens Serum Institut (SSI), Copenhagen, Denmark.; Centre for Medical Parasitology at Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Barry+A%22">Barry A</searchLink>; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso.<br /><searchLink fieldCode="AU" term="%22Yaro+JBB%22">Yaro JBB</searchLink>; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso.<br /><searchLink fieldCode="AU" term="%22Ezinmegnon+S%22">Ezinmegnon S</searchLink>; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso.<br /><searchLink fieldCode="AU" term="%22Henry+N%22">Henry N</searchLink>; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso.<br /><searchLink fieldCode="AU" term="%22Ofori+EA%22">Ofori EA</searchLink>; Department for Congenital Disorders, Statens Serum Institut (SSI), Copenhagen, Denmark.; Centre for Medical Parasitology at Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Adu+B%22">Adu B</searchLink>; Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana, Legon, Accra, Ghana.<br /><searchLink fieldCode="AU" term="%22Singh+SK%22">Singh SK</searchLink>; Department for Congenital Disorders, Statens Serum Institut (SSI), Copenhagen, Denmark.; Centre for Medical Parasitology at Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Konkobo+A%22">Konkobo A</searchLink>; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso.<br /><searchLink fieldCode="AU" term="%22Lövgren+Bengtsson+K%22">Lövgren Bengtsson K</searchLink>; Novavax AB, Uppsala, Sweden.<br /><searchLink fieldCode="AU" term="%22Diarra+A%22">Diarra A</searchLink>; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso.<br /><searchLink fieldCode="AU" term="%22Carnrot+C%22">Carnrot C</searchLink>; Novavax AB, Uppsala, Sweden.<br /><searchLink fieldCode="AU" term="%22Reimer+JM%22">Reimer JM</searchLink>; Novavax AB, Uppsala, Sweden.<br /><searchLink fieldCode="AU" term="%22Ouedraogo+A%22">Ouedraogo A</searchLink>; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso.<br /><searchLink fieldCode="AU" term="%22Tienta+M%22">Tienta M</searchLink>; Malaria Research and Training Center, Mali-National Institute of Allergy and Infectious Diseases International Center for Excellence in Research, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali.<br /><searchLink fieldCode="AU" term="%22Long+CA%22">Long CA</searchLink>; Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Ouedraogo+IN%22">Ouedraogo IN</searchLink>; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso.<br /><searchLink fieldCode="AU" term="%22Sagara+I%22">Sagara I</searchLink>; Malaria Research and Training Center, Mali-National Institute of Allergy and Infectious Diseases International Center for Excellence in Research, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali.<br /><searchLink fieldCode="AU" term="%22Sirima+SB%22">Sirima SB</searchLink>; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso.<br /><searchLink fieldCode="AU" term="%22Theisen+M%22">Theisen M</searchLink>; Department for Congenital Disorders, Statens Serum Institut (SSI), Copenhagen, Denmark.; Centre for Medical Parasitology at Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%227802877%22">The Journal of clinical investigation</searchLink> [J Clin Invest] 2024 Apr 01; Vol. 134 (7). <i>Date of Electronic Publication: </i>2024 Apr 01. – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Trial, Phase I; Randomized Controlled Trial; Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+for+Clinical+Investigation%22">American Society for Clinical Investigation </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7802877 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1558-8238 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200219738%22">00219738 </searchLink><i>NLM ISO Abbreviation: </i>J Clin Invest <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38290009 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1172/JCI175707 Languages: – Code: eng Text: English Titles: – TitleFull: A randomized first-in-human phase I trial of differentially adjuvanted Pfs48/45 malaria vaccines in Burkinabé adults. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Tiono AB – PersonEntity: Name: NameFull: Plieskatt JL – PersonEntity: Name: NameFull: Ouedraogo A – PersonEntity: Name: NameFull: Soulama BI – PersonEntity: Name: NameFull: Miura K – PersonEntity: Name: NameFull: Bougouma EC – PersonEntity: Name: NameFull: Naghizadeh M – PersonEntity: Name: NameFull: Barry A – PersonEntity: Name: NameFull: Yaro JBB – PersonEntity: Name: NameFull: Ezinmegnon S – PersonEntity: Name: NameFull: Henry N – PersonEntity: Name: NameFull: Ofori EA – PersonEntity: Name: NameFull: Adu B – PersonEntity: Name: NameFull: Singh SK – PersonEntity: Name: NameFull: Konkobo A – PersonEntity: Name: NameFull: Lövgren Bengtsson K – PersonEntity: Name: NameFull: Diarra A – PersonEntity: Name: NameFull: Carnrot C – PersonEntity: Name: NameFull: Reimer JM – PersonEntity: Name: NameFull: Ouedraogo A – PersonEntity: Name: NameFull: Tienta M – PersonEntity: Name: NameFull: Long CA – PersonEntity: Name: NameFull: Ouedraogo IN – PersonEntity: Name: NameFull: Sagara I – PersonEntity: Name: NameFull: Sirima SB – PersonEntity: Name: NameFull: Theisen M IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 04 Text: 2024 Apr 01 Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1558-8238 Numbering: – Type: volume Value: 134 – Type: issue Value: 7 Titles: – TitleFull: The Journal of clinical investigation Type: main |
| ResultId | 1 |